Hillstream BioPharma (HILS) Selects OncoBay Clinical to Advance Development of HSB-1216 Apr 13, 2023 08:48AM
Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism Apr 13, 2023 08:47AM